IL33 and gastric cancer: Utilizing mouse models, we identified an IL33-MC-macrophage axis promoting gastric cancer growth where either ST2-deficiency, lack of MCs or lack of macrophages all restricted gastric cancer growth in the preclinical gp130FF mouse model of inflammation-associated gastric cancer.